drugset / Trial / NCT05127369
Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a single center phase I / II clinical trial. Randomized, blind and positive drug parallel control were used to evaluate the safety and effectiveness of dental pulp mesenchymal cell injection in the treatment of depression 8 weeks after administration
Timeline
- Start
- 2022-01-01
- Primary completion
- 2023-12-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dental pulp mesenchymal cell injection | Unknown | 0.1 iu/kg | Intravenous |
| Subject | Fluoxetine | Small molecule | 40 mg | Oral |